All In Biotech

Free tool

Drug Search

Every brand-name drug and biologic application (NDA or BLA) in Drugs@FDA: 5,899 in all. Generic (ANDA) applications are not listed; their reference drug is.

Last checked: Nov 20, 2026Drugs@FDA last updated: Nov 18, 2026Methods & limitations

9 matches for "Celltrion, Inc."

Brand names that start with your search come first, then marketed and novel drugs.

DrugSponsorApplicationFirst approvedPrograms
Avtozma

Tocilizumab-Anoh

Celltrion INCBLA761498Jan 21, 2026
Avtozma

Tocilizumab-Anoh

Celltrion INCBLA761420Jan 24, 2025
Truxima

Rituximab-Abbs

Celltrion INCBLA761088Nov 28, 2018
Omlyclo

Omalizumab-Igec

Celltrion INCBLA761399Mar 7, 2025
Herzuma

Trastuzumab-Pkrb

Celltrion INCBLA761091Dec 14, 2018
Steqeyma

Ustekinumab-Stba

Celltrion, Inc.BLA761338Dec 17, 2024
Osenvelt

Denosumab-Bmwo

Celltrion INCBLA761404Feb 28, 2025
Eydenzelt

Aflibercept-Boav

Celltrion INCBLA761377Oct 2, 2025
Inflectra

Infliximab-Dyyb

Celltrion INCBLA125544Apr 5, 2016

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.